Videos

‘No Stupid Questions’ for Newly Diagnosed Patients With Cancer

January 6th 2024, 3:00pm

Video

An expert stressed the importance of finding a patient support group and asking questions after being diagnosed with kidney — or any other form — of cancer.

Assessing Treatment Response in Patients With Myelofibrosis

January 5th 2024, 1:30pm

Video

Response is assessed in patients starting a JAK inhibitor by monitoring symptoms on a severity scale, spleen size, blood counts, and overall patient impression of change, with the goal being reduction of symptoms and stabilization of blood counts to improve quality of life.

Adverse Events Seen With JAK Inhibitors for Myelofibrosis

January 5th 2024, 1:00pm

Video

The JAK inhibitors approved for myelofibrosis have common side effects of cytopenias and gastrointestinal issues, with additional risks of weight gain and cardiac effects and diarrhea; momelotinib and pacritinib show improved tolerability compared to earlier JAK inhibitors.

Clinical Data on the Approved JAK Inhibitors for Treatment of Myelofibrosis

December 29th 2023, 1:30pm

Video

An expert discusses the four FDA-approved JAK inhibitors for myelofibrosis - ruxolitinib, fedratinib, pacritinib, and momelotinib.

Management of Anemia in Patients With Myelofibrosis

December 29th 2023, 1:00pm

Video

Christine Cooper, RN, BSN, explains anemia in myelofibrosis is managed by stimulating red blood cell production with medications, transfusions, and newer therapies that may stabilize red cell counts.

MPN Outcomes Have Improved in the Last 20 Years

December 28th 2023, 2:00pm

Video

A doctor reflected on what it was like treating patients with myeloproliferative neoplasms years ago and how much treatments have improved.

MPN Field Is Filled With Research, Hope

December 26th 2023, 2:00pm

Video

New treatments and ongoing trials are providing more options and better outcomes for patients with myeloproliferative neoplasms, an expert explained.

MPN Survivor Discusses Her Biggest Regret After Being Diagnosed

December 25th 2023, 2:00pm

Video

After being diagnosed with essential thrombocythemia, Marilyn Kay Edwards was not told much about her disease.

Key Patient Goals for Myelofibrosis Management

December 22nd 2023, 1:30pm

Video

Key patient goals for managing myelofibrosis include improving quality of life by addressing low blood counts and constitutional symptoms, considering disease-modifying therapies and transplant to maximize longevity based on predicted survival, and incorporating personalized priorities through shared decision-making with their doctor when choosing treatments.

Educational Resources for Patients Diagnosed With Myelofibrosis

December 22nd 2023, 1:00pm

Video

Patients should be directed to resources like the NCCN guidelines and ClinicalTrials.gov and provided with thorough discussions covering frequency of visits, required testing, medication administration, side effects to enable fully informed decisions.